Select Publications
Journal articles
2016, 'Relationship between use of general practice and healthcare costs at the end of life: A data linkage study in New South Wales, Australia', BMJ Open, 6, pp. e009410, http://dx.doi.org/10.1136/bmjopen-2015-009410
,2016, 'Visualising linked health data to explore health events around preventable hospitalisations in NSW Australia', BMJ Open, 6, pp. e012031, http://dx.doi.org/10.1136/bmjopen-2016-012031
,2015, 'Association of continuity of primary care and statin adherence', PLoS ONE, 10, pp. e0140008, http://dx.doi.org/10.1371/journal.pone.0140008
,2015, 'Corrigendum to "The impact of blood-borne viruses on cause-specific mortality among opioid dependent people: An Australian population-based cohort study" [Drug Alcohol Depend. 152C (2015) 264-271] DOI: 10.1016/j.drugalcdep.2015.03.026', Drug and Alcohol Dependence, 154, pp. 304, http://dx.doi.org/10.1016/j.drugalcdep.2015.06.024
,2015, 'The impact of blood-borne viruses on cause-specific mortality among opioid dependent people: An Australian population-based cohort study', Drug and Alcohol Dependence, 152, pp. 264 - 271, http://dx.doi.org/10.1016/j.drugalcdep.2015.03.026
,2015, 'Smoking and potentially preventable hospitalisation: The benefit of smoking cessation in older ages', Drug and Alcohol Dependence, 150, pp. 85 - 91, http://dx.doi.org/10.1016/j.drugalcdep.2015.02.028
,2015, 'Sociodemographic and health characteristics, rather than primary care supply, are major drivers of geographic variation in preventable hospitalizations in Australia', Medical Care, 53, pp. 436 - 445, http://dx.doi.org/10.1097/MLR.0000000000000342
,2015, 'Opioid substitution therapy is associated with increased detection of hepatitis C virus infection: A 15-year observational cohort study', Drug and Alcohol Dependence, 148, pp. 213 - 216, http://dx.doi.org/10.1016/j.drugalcdep.2014.12.027
,2015, 'Diagnosis of hepatitis c virus infection after entry to opioid substitution therapy', Drug and Alcohol Dependence, 156, pp. e122 - e122, http://dx.doi.org/10.1016/j.drugalcdep.2015.07.337
,2014, 'Lymphoid neoplasm incidence by WHO subtype in Australia 1982-2006', International Journal of Cancer, 135, pp. 2146 - 2156, http://dx.doi.org/10.1002/ijc.28849
,2014, 'The contribution of geography to disparities in preventable hospitalisations between indigenous and non-indigenous Australians', PLoS ONE, 9, http://dx.doi.org/10.1371/journal.pone.0097892
,2014, 'Health behaviours and potentially preventable hospitalisation: A prospective study of older Australian adults', PLoS ONE, 9, pp. e93111, http://dx.doi.org/10.1371/journal.pone.0093111
,2014, 'Minimal excess risk of cancer and reduced risk of death from cancer in Australian Department of Veterans' Affairs clients: A record linkage study', Australian and New Zealand Journal of Public Health, 38, pp. 30 - 34, http://dx.doi.org/10.1111/1753-6405.12168
,2013, 'Factors influencing adherence in long-term use of statins', Pharmacoepidemiology and Drug Safety, 22, pp. 1298 - 1307, http://dx.doi.org/10.1002/pds.3526
,2013, 'Disentangling the impacts of geography and Aboriginality on serious road transport injuries in New South Wales', Accident Analysis and Prevention, 54, pp. 32 - 38, http://dx.doi.org/10.1016/j.aap.2013.01.015
,2013, 'Latitude gradients for lymphoid neoplasm subtypes in Australia support an association with ultraviolet radiation exposure', International Journal of Cancer, 133, pp. 944 - 951, http://dx.doi.org/10.1002/ijc.28081
,2013, 'OP08 Using Linked Administrative Data and Multilevel Modelling to Identify Targets for Interventions to Tackle Health Disparities', Journal of Epidemiology and Community Health, 67, pp. A7.1 - A7, http://dx.doi.org/10.1136/jech-2013-203126.8
,2012, 'Assessing Preventable Hospitalisation InDicators (APHID): Protocol for a data-linkage study using cohort study and administrative data', BMJ Open, 2, http://dx.doi.org/10.1136/bmjopen-2012-002344
,2012, 'Trends in planned early birth: A population-based study', American Journal of Obstetrics and Gynecology, 207, pp. 186.e1 - 186.e8, http://dx.doi.org/10.1016/j.ajog.2012.06.082
,2012, 'Development of a maternity hospital classification for perinatal research', NSW Public Health Bulletin, 1, pp. 12 - 16
,2012, 'Self-reported history of infections and the risk of non-Hodgkin lymphoma: An InterLymph pooled analysis', International Journal of Cancer, 131, pp. 2342 - 2348, http://dx.doi.org/10.1002/ijc.27438
,2010, 'Birth order and risk of non-Hodgkins Lymphoma - true association or bias?', American Journal of Epidemiology, 172, pp. 621 - 630, http://dx.doi.org/10.1093/aje/kwq167
,2009, 'Atopic disease and risk of non-Hodgkin lymphoma: An interlymph pooled analysis', Cancer research, 69, pp. 6482 - 6489
,2009, 'The safety of candidate vaginal microbicides since nonoxynol-9: A systematic review of published studies', AIDS, 23, pp. 1245 - 1254
,2008, 'Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph consortium', Blood, 111, pp. 4029 - 4038, http://dx.doi.org/10.1182/blood-2007-10-119974
,2007, 'Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis', Lancet, 370, pp. 59 - 67, http://dx.doi.org/10.1016/S0140-6736(07)61050-2
,Conference Papers
2021, 'Comparison of 10-and 15-year outcomes of bioprosthetic and mechanical aortic valve replacement in patients aged under 65 years: Australian study using linked data for 4,704 patients', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, pp. 48 - 48, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000687807300097&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2012, 'IS TUMOUR HER-2 STATUS A PROGNOSTIC FACTOR IN GASTRIC AND OESOPHAGEAL CANCERS? A SYSTEMATIC REVIEW', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, pp. 59 - 59, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000306960100051&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2012, 'Outcomes of planned birth before the due date', in AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, MOSBY-ELSEVIER, TX, Dallas, pp. S279 - S280, presented at 32nd Annual Scientific Meeting/Pregnancy Meeting of Society-for-Maternal-Fetal-Medicine, TX, Dallas, 06 February 2012 - 11 February 2012, http://dx.doi.org/10.1016/j.ajog.2011.10.640
,2009, 'Trends in severe pedestrian injuries among older people in NSW', in 2009 Australasian Road Safety Research, Policing and Education Conference, Roads and Traffic Authority of New South Wales, Australia, Sydney, Australia, presented at 2009 Australasian Road Safety Research, Policing and Education Conference, Sydney, Australia, 10 November 2009 - 13 November 2009, http://www.rsconference.com/roadsafety/detail/988
,Conference Presentations
2022, 'Temporal trends in rates and risk-adjusted outcomes for coronary revascularization in New South Wales (2003-2017)', presented at UNSW Annual Cardiovascular Symposium 2022, UNSW Sydney, 05 April 2022 - 05 April 2022
,Conference Abstracts
2023, 'Adherence and persistence to cardiovascular medicines in Australia among people initiating therapy in 2018', in Adherence and persistence to cardiovascular medicines in Australia among people initiating therapy in 2018, presented at 39th International Conference on Pharmacoepidemiology & Therapeutic Risk Management 2023
,2023, 'Trends in the use of Cardiometabolic Medicines in Australia (2014-2022): Sodium-glucose Co-transporter 2 Inhibitors and Glucagon-like Peptide-1 Analogues', in Trends in the use of Cardiometabolic Medicines in Australia (2014-2022): Sodium-glucose Co-transporter 2 Inhibitors and Glucagon-like Peptide-1 Analogues, presented at Australian Diabetes Congress 2023
,2023, 'Trends in use of sodium-glucose co-transporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 analogues (GLP-1a) for cardiovascular risk in Australia (2014-2022)', in Trends in use of sodium-glucose co-transporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 analogues (GLP-1a) for cardiovascular risk in Australia (2014-2022), presented at 39th International Conference on Pharmacoepidemiology & Therapeutic Risk Management 2023
,2023, 'Comparison of Outcomes for Major Contemporary Endograft Devices Used for Endovascular Repair of Intact Abdominal Aortic Aneurysms', in Journal of Vascular Surgery, Elsevier, Vol. 77, pp. 1293, http://dx.doi.org/10.1016/j.jvs.2023.01.009
,2022, 'Interaction effects of multimorbidity and frailty on adverse health outcomes in elderly hospitalised patients', in Scientific Reports, Vol. 12, http://dx.doi.org/10.1038/s41598-022-18346-x
,2022, 'Comparison of outcomes for major contemporary endograft devices used for endovascular repair of intact abdominal aortic aneurysms', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 31, pp. 466 - 467
,2022, 'Understanding opioid use prior to and immediately following cancer diagnosis using group-based trajectory models (GBTM)', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 31, pp. 525 - 526, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000859084402246&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2021, 'Rates of low value care in NSW public hospitals: variation between public and private inpatients', in INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, OXFORD UNIV PRESS, Vol. 50, http://dx.doi.org/10.1093/ije/dyab168.195
,2021, 'Predictors and Sources of Variation in 30-day Unplanned Readmission Following Isolated Coronary Artery Bypass Graft (CABG) Surgery in Australia', in Heart Lung and Circulation, Elsevier, Vol. 30, pp. s258, presented at 69th CSANZ Annual Scientific Meeting 43rd Annual Scientific Meeting of the International Society for Heart Research ANZET 21, http://dx.doi.org/10.1016/j.hlc.2021.06.362
,2020, 'Antihypertensive polytherapy in Australia: Prevalence of inappropriate combinations, 2013-2018', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 29, pp. 198 - 199
,2020, 'Long-term trajectories of medicine use among older adults experiencing polypharmacy in Australia', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Virtual, Vol. 29, pp. 199 - 199, presented at 36th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Virtual, 16 September 2020
,2018, 'Using Australia’s National Data Linkage Demonstration Project (NDLDP) to improve cardiac care: Towards a national, whole-of-population linked data resource for evidence-informed health policy', in International Journal of Population Data Science, Swansea University, Banff, Canada, Vol. 3, presented at International Population Data Linkage Conference 2018, Banff, Canada, http://dx.doi.org/10.23889/ijpds.v3i4.640
,2018, 'P2Y12 Inhibitor Therapy is Underutilised in Patients Hospitalised for Acute Myocardial Infarction: Results From a New Population-Level Data Linkage in Australia', in Heart, Lung and Circulation, Elsevier, Brisbane, Australia, Vol. 27, pp. s333, presented at Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand, Brisbane, Australia, http://dx.doi.org/10.1016/j.hlc.2018.06.647
,2018, 'Use of Oral Anticoagulants After Hospital Discharge in Patients With Atrial Fibrillation: Insights From a New Population-Level Linkage in Australia', in Heart, Lung and Circulation, Elsevier, Vol. 27, pp. s356, presented at Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand, http://dx.doi.org/10.1016/j.hlc.2018.06.701
,2015, 'The Contribution Of Geography And Risk Factors To Inequalities In Unintentional Injury Between Aboriginal And Non-Aboriginal Australian Children', in ISEE Conference Abstracts, Environmental Health Perspectives, Vol. 2015, http://dx.doi.org/10.1289/isee.2015.2015-349
,Reports
2022, Health Care Homes trial final evaluation report, Volume 1: Summary report, https://www.health.gov.au/sites/default/files/documents/2022/08/evaluation-of-the-health-care-homes-trial-final-evaluation-report-2022-summary-report.pdf
,2022, Health Care Homes trial final evaluation report, Volume 2: Main report, https://www.health.gov.au/resources/publications/evaluation-of-the-health-care-homes-trial-final-evaluation-report-2022
,2022, Health Care Homes trial final evaluation report, Volume 3: Methods and data supplement, https://www.health.gov.au/sites/default/files/documents/2022/08/evaluation-of-the-health-care-homes-trial-final-evaluation-report-2022-methods-and-data-supplement.pdf
,2021, Health Care Homes PHN Benchmark Report: July 2020 - December 2020 (Round 5)
,